Bingham Private Wealth’s AbbVie ABBV Stock Holding History

Bingham Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.17M	Buy	8,615 +2,211	+35%	+$476K	1.49%	13
2026 Q1	$1.39M	Buy	6,404 +1,385	+28%	+$307K	1.11%	25
2025 Q4	$1.15M	Buy	+5,019	New	+$1.14M	0.99%	27
2025 Q2	$1.08M	Sell	5,840 -608	-9%	-$113K	1.03%	25
2025 Q1	$1.35M	Sell	6,448 -545	-8%	-$106K	1.4%	17
2024 Q4	$1.24M	Buy	+6,993	New	+$1.29M	1.32%	17

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bingham Private Wealth's ABBV Position: Q2 2026 in Review

Bingham Private Wealth increased its AbbVie (ABBV) stake by 35% in Q2 2026, buying an estimated $476K and bringing the position to 8,615 shares worth $2.17M. The position accounts for 1.49% of the portfolio, ranked #13.

Bingham Private Wealth first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bingham Private Wealth held 8,615 shares of AbbVie worth $2.17M as of Q2 2026.
Bingham Private Wealth bought 2,211 AbbVie shares in Q2 2026, an estimated $476K.
AbbVie made up 1.49% of Bingham Private Wealth's portfolio in Q2 2026, its #13 holding.
Bingham Private Wealth first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bingham Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.